Torrent Pharmaceuticals has successfully raised ₹12,500 crore via debentures, a strategic move to finance its takeover of JB Chemicals & Pharmaceuticals. By issuing commercial papers and non-convertible debentures with varying maturities, Torrent attracted investments from mutual funds, insurance firms, and pension funds. This financing decision underscores Torrent’s ambition to enhance its market presence and broaden its therapeutic offerings.
Related Posts
Weak rupee takes its toll on cos with huge foreign debt
- nationalpillarnews
- January 9, 2026
- 0
The falling rupee will severely affect the small companies, whereas the big ones will be impacted moderately. Get rid of Debt | Adopt correct investment […]
Ashish Kacholia-backed Balu Forge shares bounce back 13% after sharp YTD fall
- nationalpillarnews
- January 13, 2026
- 0
Balu Forge Industries shares surged up to 13% intraday after the company clarified that a recent Income Tax Department search concluded without finding any incriminating […]